S Fitzpatrick1, R Joks, J I Silverberg. 1. Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, USA.
Abstract
BACKGROUND: Obesity is associated with increased asthma and atopy. OBJECTIVE: To determine whether or not obesity in inner-city adults is associated with increased asthma prevalence, severity and exacerbations and IgE responses. METHODS: This retrospective study involved 246 adults with asthma and other atopic disorders who were seen at an asthma clinic in New York City between 1997 and 2010. Height, weight, asthma diagnosis and symptoms, peak flow (PF), spirometry, serum IgE levels and white blood cell differentials were recorded. RESULTS: Asthmatic patients had higher body mass index than non-asthmatics (median, interquartile range: 30.5, 10.2 vs. 27.8, 8.8; Mann-Whitney U-test, P = 0.0006). Class I and II/III obesity were associated with increased asthma (I: OR: 2.35, 95% CI: 1.04-5.34, P = 0.04; II/III: OR: 3.25, 95% CI: 1.36-7.74, P = 0.008). Class I and II/III obesity were associated with worsened asthma severity (ordinal logistic regression; I: OR: 4.23, 95% CI: 1.61-11.06, P = 0.003; II/III: OR: 2.76, 95% CI: 1.08-7.09, P = 0.03). Class II/III obesity was associated with increased asthma exacerbations requiring oral corticosteroids (repeated measures logistic regression, OR: 1.13, 95% CI: 1.03-1.25; P = 0.01) and increased requirement of inhaled corticosteroid for long-term asthma management (OR: 1.45, 95% CI: 1.29-1.62; P < 0.0001). In asthmatics, class II/III obesity was associated with decreased PF (general linear model, least squares mean ± SEM: 333.8 ± 37.4 vs. 396.2 ± 32.1 L/min; P = 0.007), forced expiratory volume in 1 s (75.2 ± 4.6 vs. 88.4 ± 5.6%; P = 0.03) and forced vital capacity (83.2 ± 4.7 vs. 109.2 ± 6.0%; P = 0.0002) and increased serum IgE (480.2 ± 88.3 vs. 269.0 ± 66.6 IU/mL; P = 0.04) and neutrophils (66.6 ± 3.7 vs. 60.1 ± 3.8%; P = 0.02). Class I obesity was also associated with increased serum IgE (458.7 ± 68.9, P = 0.03). CONCLUSION AND CLINICAL RELEVANCE: Obesity in inner-city adults may be both a risk and exacerbating factor for atopic asthma.
BACKGROUND:Obesity is associated with increased asthma and atopy. OBJECTIVE: To determine whether or not obesity in inner-city adults is associated with increased asthma prevalence, severity and exacerbations and IgE responses. METHODS: This retrospective study involved 246 adults with asthma and other atopic disorders who were seen at an asthma clinic in New York City between 1997 and 2010. Height, weight, asthma diagnosis and symptoms, peak flow (PF), spirometry, serum IgE levels and white blood cell differentials were recorded. RESULTS: Asthmatic patients had higher body mass index than non-asthmatics (median, interquartile range: 30.5, 10.2 vs. 27.8, 8.8; Mann-Whitney U-test, P = 0.0006). Class I and II/III obesity were associated with increased asthma (I: OR: 2.35, 95% CI: 1.04-5.34, P = 0.04; II/III: OR: 3.25, 95% CI: 1.36-7.74, P = 0.008). Class I and II/III obesity were associated with worsened asthma severity (ordinal logistic regression; I: OR: 4.23, 95% CI: 1.61-11.06, P = 0.003; II/III: OR: 2.76, 95% CI: 1.08-7.09, P = 0.03). Class II/III obesity was associated with increased asthma exacerbations requiring oral corticosteroids (repeated measures logistic regression, OR: 1.13, 95% CI: 1.03-1.25; P = 0.01) and increased requirement of inhaled corticosteroid for long-term asthma management (OR: 1.45, 95% CI: 1.29-1.62; P < 0.0001). In asthmatics, class II/III obesity was associated with decreased PF (general linear model, least squares mean ± SEM: 333.8 ± 37.4 vs. 396.2 ± 32.1 L/min; P = 0.007), forced expiratory volume in 1 s (75.2 ± 4.6 vs. 88.4 ± 5.6%; P = 0.03) and forced vital capacity (83.2 ± 4.7 vs. 109.2 ± 6.0%; P = 0.0002) and increased serum IgE (480.2 ± 88.3 vs. 269.0 ± 66.6 IU/mL; P = 0.04) and neutrophils (66.6 ± 3.7 vs. 60.1 ± 3.8%; P = 0.02). Class I obesity was also associated with increased serum IgE (458.7 ± 68.9, P = 0.03). CONCLUSION AND CLINICAL RELEVANCE: Obesity in inner-city adults may be both a risk and exacerbating factor for atopic asthma.
Authors: F M C Silva; E E Oliveira; A C C Gouveia; A S S Brugiolo; C C Alves; J O A Correa; J Gameiro; J Mattes; H C Teixeira; A P Ferreira Journal: Clin Exp Immunol Date: 2017-03-31 Impact factor: 4.330
Authors: Erick Esteves de Oliveira; Flávia Márcia de Castro E Silva; Marina Caçador Ayupe; Marcilene Gomes Evangelista Ambrósio; Viviane Passos de Souza; Gilson Costa Macedo; Ana Paula Ferreira Journal: Immunology Date: 2019-07 Impact factor: 7.397
Authors: Njira Lugogo; Cynthia L Green; Noah Agada; Siyi Zhang; Susanne Meghdadpour; Run Zhou; Siyun Yang; Kevin J Anstrom; Elliot Israel; Richard Martin; Robert F Lemanske; Homer Boushey; Stephen C Lazarus; Stephen I Wasserman; Mario Castro; William Calhoun; Stephen P Peters; Emily DiMango; Vernon Chinchilli; Susan Kunselman; Tonya S King; Nikolina Icitovic; Monica Kraft Journal: J Allergy Clin Immunol Date: 2017-06-15 Impact factor: 10.793
Authors: James G Wagner; Neil P Birmingham; Daven Jackson-Humbles; Qing Jiang; Jack R Harkema; David B Peden Journal: Free Radic Biol Med Date: 2013-12-11 Impact factor: 7.376
Authors: Anunya Hiranrattana; Debra A Stern; Stefano Guerra; Marilyn Halonen; Anne L Wright; Michael Daines; Fernando D Martinez; Wayne J Morgan Journal: Thorax Date: 2018-03-21 Impact factor: 9.139
Authors: N Sismanopoulos; D-A Delivanis; D Mavrommati; E Hatziagelaki; P Conti; T C Theoharides Journal: Allergy Date: 2012-10-16 Impact factor: 13.146